78 related articles for article (PubMed ID: 29879676)
21. POFA trial study protocol: a multicentre, double-blind, randomised, controlled clinical trial comparing opioid-free versus opioid anaesthesia on postoperative opioid-related adverse events after major or intermediate non-cardiac surgery.
Beloeil H; Laviolle B; Menard C; Paugam-Burtz C; Garot M; Asehnoune K; Minville V; Cuvillon P; Oger S; Nadaud J; Lecoeur S; Chanques G; Futier E;
BMJ Open; 2018 Jun; 8(6):e020873. PubMed ID: 29961015
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.
Bartlett EA; DeLorenzo C; Sharma P; Yang J; Zhang M; Petkova E; Weissman M; McGrath PJ; Fava M; Ogden RT; Kurian BT; Malchow A; Cooper CM; Trombello JM; McInnis M; Adams P; Oquendo MA; Pizzagalli DA; Trivedi M; Parsey RV
Neuropsychopharmacology; 2018 Oct; 43(11):2221-2230. PubMed ID: 29955151
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial.
Hayashida T; Jinno H; Mori K; Sato H; Matsui A; Sakurai T; Hattori H; Takayama S; Wada M; Takahashi M; Seki H; Seki T; Nagayama A; Matsumoto A; Kitagawa Y
BMC Cancer; 2018 Jun; 18(1):701. PubMed ID: 29954362
[TBL] [Abstract][Full Text] [Related]
24. The prebiotic inulin improves substrate metabolism and promotes short-chain fatty acid production in overweight to obese men.
van der Beek CM; Canfora EE; Kip AM; Gorissen SHM; Olde Damink SWM; van Eijk HM; Holst JJ; Blaak EE; Dejong CHC; Lenaerts K
Metabolism; 2018 Oct; 87():25-35. PubMed ID: 29953876
[TBL] [Abstract][Full Text] [Related]
25. Study protocol and rationale for a prospective, randomized, double-blind, placebo-controlled study to evaluate the effects of Ashwagandha (Withania somnifera) extract on nonrestorative sleep.
Deshpande A; Irani N; Balakrishnan R
Medicine (Baltimore); 2018 Jun; 97(26):e11299. PubMed ID: 29953014
[TBL] [Abstract][Full Text] [Related]
26. Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with
Lim HY; Merle P; Weiss KH; Yau T; Ross P; Mazzaferro V; Blanc JF; Ma YT; Yen CJ; Kocsis J; Choo SP; Sukeepaisarnjaroen W; Gérolami R; Dufour JF; Gane EJ; Ryoo BY; Peck-Radosavljevic M; Dao T; Yeo W; Lamlertthon W; Thongsawat S; Teufel M; Roth K; Reis D; Childs BH; Krissel H; Llovet JM
Clin Cancer Res; 2018 Oct; 24(19):4650-4661. PubMed ID: 29950351
[No Abstract] [Full Text] [Related]
27. Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth.
Widmer M; Piaggio G; Nguyen TMH; Osoti A; Owa OO; Misra S; Coomarasamy A; Abdel-Aleem H; Mallapur AA; Qureshi Z; Lumbiganon P; Patel AB; Carroli G; Fawole B; Goudar SS; Pujar YV; Neilson J; Hofmeyr GJ; Su LL; Ferreira de Carvalho J; Pandey U; Mugerwa K; Shiragur SS; Byamugisha J; Giordano D; Gülmezoglu AM;
N Engl J Med; 2018 Aug; 379(8):743-752. PubMed ID: 29949473
[TBL] [Abstract][Full Text] [Related]
28. THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.
Gianchandani RY; Pasquel FJ; Rubin DJ; Dungan KM; Vellanki P; Wang H; Anzola I; Gomez P; Hodish I; Lathkar-Pradhan S; Iyengar J; Umpierrez GE
Endocr Pract; 2018 Jun; 24(6):556-564. PubMed ID: 29949432
[TBL] [Abstract][Full Text] [Related]
29. Safety and Tolerability of Combinations of Empagliflozin and Linagliptin in Patients with Type 2 Diabetes: Pooled Data from Two Randomized Controlled Trials.
DeFronzo RA; Lee C; Kohler S
Adv Ther; 2018 Jul; 35(7):1009-1022. PubMed ID: 29949041
[TBL] [Abstract][Full Text] [Related]
30. A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.
Pereira MJ; Lundkvist P; Kamble PG; Lau J; Martins JG; Sjöström CD; Schnecke V; Walentinsson A; Johnsson E; Eriksson JW
Diabetes Ther; 2018 Aug; 9(4):1511-1532. PubMed ID: 29949016
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial.
Nauck MA; Tornøe K; Rasmussen S; Treppendahl MB; Marso SP;
Diab Vasc Dis Res; 2018 Sep; 15(5):465-468. PubMed ID: 29947247
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetes.
Müller-Wieland D; Kellerer M; Cypryk K; Skripova D; Rohwedder K; Johnsson E; Garcia-Sanchez R; Kurlyandskaya R; Sjöström CD; Jacob S; Seufert J; Dronamraju N; Csomós K
Diabetes Obes Metab; 2018 Nov; 20(11):2598-2607. PubMed ID: 29947099
[TBL] [Abstract][Full Text] [Related]
33. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
Insogna KL; Briot K; Imel EA; Kamenický P; Ruppe MD; Portale AA; Weber T; Pitukcheewanont P; Cheong HI; Jan de Beur S; Imanishi Y; Ito N; Lachmann RH; Tanaka H; Perwad F; Zhang L; Chen CY; Theodore-Oklota C; Mealiffe M; San Martin J; Carpenter TO;
J Bone Miner Res; 2018 Aug; 33(8):1383-1393. PubMed ID: 29947083
[TBL] [Abstract][Full Text] [Related]
34. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
[TBL] [Abstract][Full Text] [Related]
35. A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia.
Su Q; Chen SL; Wang HH; Liang LX; Dai N; Lyu B; Zhang J; Wang RQ; Zhang YL; Yu Y; Liu JS; Hou XH
Chin Med J (Engl); 2018 Jul; 131(13):1549-1556. PubMed ID: 29941708
[TBL] [Abstract][Full Text] [Related]
36. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.
Corsale I; Carrieri P; Martellucci J; Piccolomini A; Verre L; Rigutini M; Panicucci S
Int J Colorectal Dis; 2018 Nov; 33(11):1595-1600. PubMed ID: 29934701
[TBL] [Abstract][Full Text] [Related]
37. Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With Pioglitazone.
Young LH; Viscoli CM; Schwartz GG; Inzucchi SE; Curtis JP; Gorman MJ; Furie KL; Conwit R; Spatz ES; Lovejoy A; Abbott JD; Jacoby DL; Kolansky DM; Ling FS; Pfau SE; Kernan WN;
Circulation; 2018 Sep; 138(12):1210-1220. PubMed ID: 29934374
[TBL] [Abstract][Full Text] [Related]
38. Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study.
Singer MA; Dugel PU; Fine HF; Capone A; Maltman J
Ophthalmic Surg Lasers Imaging Retina; 2018 Jun; 49(6):425-435. PubMed ID: 29927470
[TBL] [Abstract][Full Text] [Related]
39. Statin Therapy Does Not Reduce Liver Fat Scores in Patients Receiving Antiretroviral Therapy for HIV Infection.
El Kamari V; Hileman CO; Gholam PM; Kulkarni M; Funderburg N; McComsey GA
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):536-542.e1. PubMed ID: 29908359
[TBL] [Abstract][Full Text] [Related]
40. Inspiromatic-safety and efficacy study of a new generation dry powder inhaler in asthmatic children.
Steuer G; Prais D; Mussaffi H; Mei-Zahav M; Bar-On O; Levine H; Gendler Y; Blau H; Stafler P
Pediatr Pulmonol; 2018 Oct; 53(10):1348-1355. PubMed ID: 29905977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
